Nosiheptide

Nosiheptide

56377-79-8

260-138-4

C₅₁H₄₃N₁₃O₁₂S₆

OC1=C(C2=NC(C(NC(C(N)=O)=C)=O)=CS2)N=C(C3=CSC(C(CSC(C4=C(C)C(C(CO5)=CC=C6)=C6N4)=O)NC(C7=CSC(C(CC(O)C5=O)NC8=O)=N7)=O)=N3)C(C9=NC(C(NC(C(O)C)C(N/C(C%10=NC8=CS%10)=CC)=O)=O)=CS9)=C1

30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-([2,4]-endo-thiazolomethanimino)-5h,15h,37h-pyrido[3,2-w][2,11,21,27,31,7,14,17]benzoxatetrathiatriazacyclohexatriacontine,nosiheptide deriv. ; primofax ; multhiomycin ; multiomycin ; rp 9671 ; nosiheptide ; [11s-[11r*(s*),14z,21r*,23r*,29r*]]-n-[1-(aminocarbonyl)ethenyl]-2-[14-ethylidene-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-3,23-dihydroxy-11-(1-hydroxyethyl)-31-methyl-9,12,19,24,33,43-hexaoxo-30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-([2,4]-endo-thiazolomethanimino)-5h,15h,37h-pyrido[3,2-w][2,11,21,27,31,7,14,17]benzoxatetrathiatriazacyclohexatriacontin-2-yl]-4-thiazolecarboxamide ; n-[1-(aminocarbonyl)ethenyl]-2-[(11s,14z,21s,23s,29s)-14-ethylidene-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-3,23-dihydroxy-11-[(1r)-1-hydroxyethyl]-31-methyl-9,12,19,24,33,43-hexaoxo-30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-([2,4]-endo-thiazolomethanimino)-5h,15h,37h-pyrido[3,2-w][2,11,21,27,31,7,14,17]benzoxatetrathiatriazacyclohexatriacontin-2-yl]-4-thiazolecarboxamide ; nsc 307240 ; nosiheptide vetranal ; 4-thiazolecarboxamide,n-[1-(aminocarbonyl)ethenyl]-2-[(11s,14z,21s,23s,29s)-14-ethylidene-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-3,23-dihydroxy-11-[(1r)-1-hydroxyethyl]-31-methyl-9,12,19,24,33,43-hexaoxo-30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-([2,4]-endo-thiazolomethanimino)-5h,15h,37h-pyrido[3,2-w][2,11,21,27,31,7,14,17]benzoxatetrathiatriazacyclohexatriacontin-2-yl]-